Date published: 2025-9-12

1-800-457-3801

SCBT Portrait Logo
Seach Input

AKR1CL2 Inhibitors

AKR1CL2 inhibitors are a specialized class of chemical compounds designed to inhibit the activity of the AKR1CL2 enzyme, which is part of the aldo-keto reductase (AKR) superfamily. AKR1CL2, like other members of this enzyme family, catalyzes the reduction of aldehydes and ketones to their corresponding alcohols using NADPH as a cofactor. This reduction process is crucial for various metabolic pathways, including the detoxification of reactive aldehydes and the regulation of steroids, carbohydrates, and xenobiotics. AKR1CL2 inhibitors act by binding to the enzyme's active site, where they interfere with the binding of natural substrates or cofactor molecules, effectively blocking the catalytic reduction process. These inhibitors often mimic the structure of the enzyme's substrates or transition states, which allows them to competitively inhibit the enzyme by engaging key catalytic residues, such as those involved in NADPH binding and substrate positioning.

The structural design of AKR1CL2 inhibitors is heavily guided by detailed knowledge of the enzyme's three-dimensional conformation, typically obtained through structural biology techniques like X-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy. These studies help reveal the specific features of the active site, such as hydrogen bonding networks, hydrophobic pockets, and key amino acid residues that are involved in substrate recognition and catalysis. Based on this information, inhibitors are designed with chemical groups like hydroxyls, carbonyls, or aromatic rings to interact effectively with these regions. Additionally, computational tools like molecular docking and molecular dynamics simulations are employed to predict how potential inhibitors will bind to AKR1CL2 and to optimize their binding strength and specificity. In some cases, allosteric inhibitors may also be developed to bind at sites outside the active site, inducing conformational changes that indirectly reduce the enzyme's activity. AKR1CL2 inhibitors are valuable tools for studying the enzyme's role in metabolic pathways and for gaining a deeper understanding of the biochemical mechanisms that govern the AKR enzyme family.

SEE ALSO...

Items 71 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING